Recent advances in nanotechnology-based drug delivery systems for the kidney

Fatemeh Oroojalian, Fahimeh Charbgoo, Maryam Hashemi, Amir Amani, Rezvan Yazdian-Robati, Ahad Mokhtarzadeh, Mohammad Ramezani, Michael R. Hamblin

Research output: Contribution to journalReview articlepeer-review

112 Citations (Scopus)

Abstract

The application of nanotechnology in medicine has the potential to make a great impact on human health, ranging from prevention to diagnosis and treatment of disease. The kidneys are the main organ of the human urinary system, responsible for filtering the blood, and concentrating metabolic waste into urine by means of the renal glomerulus. The glomerular filtration apparatus presents a barrier against therapeutic agents based on charge and/or molecular size. Therefore, drug delivery to the kidneys faces significant difficulties resulting in treatment failure in several renal disorders. Accordingly, different strategies have recently being explored for enhancing the delivery of therapeutic agents across the filtration barrier of the glomerulus. Nanosystems with different physicochemical properties, including size, shape, surface, charge, and possessing biological features such as high cellular internalization, low cytotoxicity, controllable pharmacokinetics and biodistribution, have shown promising results for renal therapy. Different types of nanoparticles (NPs) have been used to deliver drugs to the kidney. In this review, we discuss nanotechnology-based drug delivery approaches for acute kidney injury, chronic kidney disease, renal fibrosis, renovascular hypertension and kidney cancer.

Original languageEnglish
Pages (from-to)442-462
Number of pages21
JournalJournal of Controlled Release
Volume321
DOIs
Publication statusPublished - 10 May 2020

Keywords

  • Acute kidney injury
  • Chronic kidney disease
  • Nanomedicine
  • Renal delivery
  • Renal proximal tubular cells

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Recent advances in nanotechnology-based drug delivery systems for the kidney'. Together they form a unique fingerprint.

Cite this